Stock Market & Financial Investment News

Early research shows promise of stem cells in treating blindness, NY Post saysA clinical trial in mice published by Britain's Medical Research Council and in the science journal "Nature Biotechnology" showed that researchers were able to get blind mice to react to light after stem cell therapy, according to AFP via Fox News. Shares of StemCells (STEM), which is engaged in the research, development, and commercialization of stem cell therapies, moved about 3% higher following the report. Reference Link